Xeris Biopharma Holdings (XERS) EBIT Margin Growth (1y) (2021 - 2026)
Xeris Biopharma Holdings (XERS) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 304.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -157.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -650.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -2,102.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1,962.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 152.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -12,673.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2,276.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -583.00 |
| 10 | Xeris Biopharma Holdings | 1.11 Bn | 994.95 Mn | 72.55 Mn | 1,466.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,466.00 |
| Dec 31, 2025 | 1,675.00 |
| Sep 30, 2025 | 3,281.00 |
| Jun 30, 2025 | 2,330.00 |
| Mar 31, 2025 | 2,991.00 |
| Dec 31, 2024 | 2,496.00 |
| Sep 30, 2024 | -1,359.00 |
| Jun 30, 2024 | 2,501.00 |
| Mar 31, 2024 | 494.00 |
| Dec 31, 2023 | 2,360.00 |
| Sep 30, 2023 | 5,301.00 |
| Jun 30, 2023 | 3,271.00 |
| Mar 31, 2023 | 9,172.00 |
| Dec 31, 2022 | 17,949.00 |
| Sep 30, 2022 | 15,706.00 |
| Jun 30, 2022 | 21,480.00 |
| Mar 31, 2022 | 7,255.00 |
| Dec 31, 2021 | 4,891.00 |
| Sep 30, 2021 | -7,408.00 |